Mastocytosis: Difference between revisions

	Mastocytosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Mastocytosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Mastocytosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mastocytosis All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Mastocytosis
CDC on Mastocytosis
Mastocytosis in the news
Blogs on Mastocytosis
Directions to Hospitals Treating Mastocytosis
Risk calculators and risk factors for Mastocytosis

	Mastocytosis;
	Skin: Cutaneous Mastocytosis; childhood form (A), there is a tumoral dermal infiltrate devoid of epidermotropism and composed of bland cells with conspicuous cell boundaries and uniform, round, centrally located nuclei (B). Confirmatory cytoplasmic granules are only apparent with metachromatic stains, such as this Giemsa stain (C), or by upon ultrastructural examination (D). C, X1000. D, X65,000. ; Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology
ICD-10	Q82.2, C96.2
ICD-9	757.33, 202.6
ICD-O:	9741/3
OMIM	154800
DiseasesDB	7864
MeSH	D008415

Revision as of 00:03, 19 August 2012

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 44: / Line 44: @@
 ==Treatment==
 [[Mastocytosis medical therapy|Medical Therapy]] | [[Mastocytosis surgery|Surgery]] | [[Mastocytosis primary prevention|Primary Prevention]] | [[Mastocytosis secondary prevention|Secondary Prevention]]
-==Additional Resources==
-* ''Based on an informative page by the [[National Institute of Allergy and Infectious Diseases]] (NIAID).''
-* Shah NP, Lee FJ, Luo R, Jiang Y, Donker M, Akin C. Dasatinib (BMS-354825) inhibits KIT(D816V), an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis. Blood. 2006; 108(1):286-291. PMID 16434489.
-* Pardanani A, Teffer A. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.  Current Opinion in Hematology. 2010; 17(2): 125-132. PMID 20075725.
 ==Resources==

v t e Myeloid Hematological malignancy/leukemia histology (ICD-O 9590-9989, C81-C96, 200-208)
CFU-GM/ and other granulocytes	Template:Navbox subgroup
MEP	Template:Navbox subgroup
CFU-Mast	Mastocytoma (Mast cell leukemia, Mast cell sarcoma, Systemic mastocytosis)
Multiple/unknown	AML (Acute panmyelosis with myelofibrosis, Myeloid sarcoma) · MP (Myelofibrosis) · Acute biphenotypic leukaemia
See also hematology, lymphoid malignancy


Mastocytosis
Skin: Cutaneous Mastocytosis; childhood form (A), there is a tumoral dermal infiltrate devoid of epidermotropism and composed of bland cells with conspicuous cell boundaries and uniform, round, centrally located nuclei (B). Confirmatory cytoplasmic granules are only apparent with metachromatic stains, such as this Giemsa stain (C), or by upon ultrastructural examination (D). C, X1000. D, X65,000. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology
ICD-10	Q82.2, C96.2
ICD-9	757.33, 202.6
ICD-O:	9741/3
OMIM	154800
DiseasesDB	7864
MeSH	D008415